The U.S. Food and Drug Administration (FDA) said that it would allow makers of olive oil products to make the claim that their products might reduce the risk of coronary heart disease.
Pernod Ricard announces that it has sold its remaining interest in the Orangina soft drinks business operated by its subsidiary, CFPO, to Cadbury Schweppes.
RSS